ISU Abxis (Korea) Top Management

086890 Stock  KRW 4,465  10.00  0.22%   
ISU Abxis employs about 16 people. The company is managed by 10 executives with a total tenure of roughly 38 years, averaging almost 3.0 years of service per executive, having 1.6 employees per reported executive. Analysis of ISU Abxis' management performance can provide insight into the company performance.
ChangHoon Choi  Insider
Exec
SangHo Park  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ISU Abxis Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

ISU Abxis Management Team Effectiveness

The company has return on total asset (ROA) of (0.0463) % which means that it has lost $0.0463 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4857 %, meaning that it generated $0.4857 on every $100 dollars invested by stockholders. ISU Abxis' management efficiency ratios could be used to measure how well ISU Abxis manages its routine affairs as well as how well it operates its assets and liabilities.

ISU Abxis Workforce Comparison

ISU Abxis Co is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 536. ISU Abxis holds roughly 16.0 in number of employees claiming about 2.99% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.57) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.3) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.3.

ISU Abxis Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. ISU Abxis Price Series Summation is a cross summation of ISU Abxis price series and its benchmark/peer.

ISU Abxis Notable Stakeholders

An ISU Abxis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ISU Abxis often face trade-offs trying to please all of them. ISU Abxis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ISU Abxis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About ISU Abxis Management Performance

The success or failure of an entity such as ISU Abxis often depends on how effective the management is. ISU Abxis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ISU management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ISU management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. ISU Abxis Co., Ltd. is headquartered in Seongnam, South Korea. ISU ABXIS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of ISU Abxis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ISU Abxis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ISU Abxis' management manipulating its earnings.

ISU Abxis Workforce Analysis

Traditionally, organizations such as ISU Abxis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ISU Abxis within its industry.

ISU Abxis Manpower Efficiency

Return on ISU Abxis Manpower

Revenue Per Employee1.8B
Revenue Per Executive2.8B
Net Income Per Employee51.9M
Net Income Per Executive83M
Working Capital Per Employee1.8B
Working Capital Per Executive2.9B

Complementary Tools for ISU Stock analysis

When running ISU Abxis' price analysis, check to measure ISU Abxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISU Abxis is operating at the current time. Most of ISU Abxis' value examination focuses on studying past and present price action to predict the probability of ISU Abxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISU Abxis' price. Additionally, you may evaluate how the addition of ISU Abxis to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Valuation
Check real value of public entities based on technical and fundamental data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data